BRTX Stock Analysis: Buy, Sell, or Hold?
BRTX - BioRestorative Therapies, Inc. Common Stock (NV)
$0.19
0.00 (1.56%)
▲
5d:
-16.04%
30d:
-27.35%
90d:
-23.05%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 20, 2026
4d
Get Alerted When BRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BRTX is currently trading at $0.19, which is considered oversold relative to its 30-day fair value range of $0.21 to $0.26.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $0.17, while resistance sits at $0.26.
Market Sentiment: BRTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+4135.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $0.17, while resistance sits at $0.26.
Market Sentiment: BRTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+4135.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.21 -
$0.26
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4135.0% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-16.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.21 -
$0.26
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.17
Resistance Level
$0.26
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.36
Wall Street Target
$8.00
(+4135.0%)
Revenue Growth (YoY)
-54.7%
Share & Embed Analysis
Last updated: May 15, 2026 9:44 AM ET
Data refreshes hourly during market hours. Next update: 10:44 AM
Data refreshes hourly during market hours. Next update: 10:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 61 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 51 HOLD |
